Form 8.5 (EPT/RI) - Touchstone Exploration Inc.
September 24, 2024 03:24 ET
|
Shore Capital Stockbrokers Limited
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...
Communiqué de presse France : Sanofi devient membre fondateur de la Fondation de l’Université Paris-Saclay et apporte son soutien financier dans le cadre d’une convention de mécénat
September 24, 2024 03:11 ET
|
Sanofi - Aventis Groupe
Sanofi devient membre fondateur de la Fondation de l’Université Paris-Saclay et apporte son soutien financier dans le cadre d’une convention de mécénat Paris, le 24 septembre 2024. Sanofi et...
Blueshift Selected by RCS MediaGroup to Revolutionize Multi-Channel Customer Engagement
September 24, 2024 03:01 ET
|
Blueshift Labs, Inc.
London, United Kingdom, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Blueshift, the leading force in intelligent customer engagement, is thrilled to announce an exciting new partnership with RCS...
Utility Solar Tracker Market to reach $34.6 Bn by 2032, Says Global Market Insights Inc.
September 24, 2024 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware,, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The utility solar tracker market is projected to hit USD 34.6 billion by 2032, as reported in a research study by Global Market Insights...
Craft Named Value Leader for Supply Chain Risk Management Platform and Achieves Overall Strong Performance in Spend Matters Fall 2024 SolutionMap
September 24, 2024 03:00 ET
|
Craft
Craft, the supply chain resilience company, today announced it was named a Value Leader in the Spend Matters Fall 2024 SRM SolutionMap.
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024 03:00 ET
|
HUTCHMED (China) Limited
— Approval based on results from global Phase III FRESCO-2 trial in patients with previously treated metastatic colorectal cancer — — Fruquintinib already approved in several regions including the...
AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy
September 24, 2024 03:00 ET
|
AlgoTX
PARIS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01, announced...
Nokia selected by Spark as majority 5G RAN partner in New Zealand
September 24, 2024 03:00 ET
|
Nokia Oyj
Press ReleaseNokia selected by Spark as majority 5G RAN partner in New Zealand Nokia to partner with Spark to expand its 4G and 5G infrastructure in key cities across New Zealand.Partnership supports...
Nokia and ZCorum collaborate to develop DOCSIS Provisioning Adapter for cable-to-fiber transition
September 24, 2024 03:00 ET
|
Nokia Oyj
Press ReleaseNokia and ZCorum collaborate to develop DOCSIS Provisioning Adapter for cable-to-fiber transition Nokia entered into an agreement with ZCorum to develop a DOCSIS Provisioning Adapter...
21Shares Announces Fee Reduction for Flagship ETPs, HODLX and BOLD
September 24, 2024 03:00 ET
|
21Shares
ZURICH, 24 September 2024 – 21Shares AG ("21Shares"), one of the world's largest issuers of cryptocurrency exchange traded products (ETPs) and a subsidiary of 21.co, is pleased to announce a...